Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
TB500 is being explored as a powerful tool in regenerative therapies, especially important for addressing age-related tissue decline
Helical mutations in type I collagen that affect the processing of the amino-propeptide result in an osteogenesis imperfecta/Ehlers-Danlos syndrome overlap syndrome
No, BPC-157 is neither a hormone nor a steroid
Beyond GLP-1, the market encompasses peptide cancer therapies (Oncology Peptide Therapy at 4.1% share, 11.79% CAGR), somatostatin analogues for neuroendocrine tumours, GnRH agonists/antagonists for hormone-sensitive cancers, radioligand therapy, and reproductive medicine peptides each representing strategically important niches with their own competitive dynamics
US$ 23.27
US$ 28.23
US$ 28.78
US$ 27.99
US$ 22.05
